Spatiotemporal Dynamic of the RTS,S/AS01 Malaria Vaccine Target Antigens in Senegal.
Adolescent
Adult
Antigens, Protozoan
/ genetics
Child
Child, Preschool
DNA, Protozoan
/ analysis
Female
Humans
Malaria Vaccines
/ immunology
Malaria, Falciparum
/ microbiology
Male
Middle Aged
Plasmodium falciparum
/ genetics
Protozoan Proteins
/ genetics
Senegal
Spatio-Temporal Analysis
Vaccines, Synthetic
/ immunology
Young Adult
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
11 10 2021
11 10 2021
Historique:
received:
02
04
2021
accepted:
17
06
2021
pubmed:
12
10
2021
medline:
22
2
2022
entrez:
11
10
2021
Statut:
epublish
Résumé
The RTS,S/AS01 malaria vaccine confers only moderate protection against malaria. Evidence suggests that the effectiveness of the RTS,S/AS01 vaccine depends upon the parasite population genetics, specifically regarding the circumsporozoite protein haplotypes in the population. We investigated Plasmodium falciparum circumsporozoite protein (PfCSP) gene sequences from two endemic sites in 2018 in Senegal. The PfCSP sequences were compared with those retrieved from the Pf3k genome database. In the central repeat region of PfCSP, the distribution of haplotypes differed significantly between the two study sites (Fisher's exact test, P < 0.001). No 3D7 vaccine strain haplotype was observed in this locus. In the C-terminal region, there was no significant difference in haplotypes distribution between Kedougou and Diourbel (Fischer's exact test, P = 0.122). The 3D7 haplotype frequency was 8.4% in early samples (2001-2011), but then it contracted in the subsequent years. The extensive plasticity of the P. falciparum genes coding the RTS,S/AS01 vaccine target antigens may influence the immune responses to circulating alleles. Monitoring the genetic diversity baseline and its dynamics over time and space would be instrumental in rationally improving the malaria RTS,S/AS01 vaccine and/or its implementation schedule.
Identifiants
pubmed: 34634772
doi: 10.4269/ajtmh.21-0369
pii: tpmd210369
pmc: PMC8641351
doi:
pii:
Substances chimiques
Antigens, Protozoan
0
DNA, Protozoan
0
Malaria Vaccines
0
Protozoan Proteins
0
RTS,S-AS01 vaccine
0
Vaccines, Synthetic
0
circumsporozoite protein, Protozoan
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM